Clinical Association of Delayed Villous Maturation in Gestational Diabetes Mellitus Pregnancy: A Prospective Study

Document Type : Original Research

Authors

1 Department of Anatomy, KLE Jagadguru Gangadhar Mahaswamigalu Moorusavirmath Medical College and Hospital, Hubballi, KLE Academy of Higher Education and Research, Deemed to be University , Belagavi, Karnataka, India- 59010, Faculty of Medicine, KLE Academy of Higher Education and Research, Deemed to be University, Belagavi, Karnataka, India- 59010, Hubballi, India

2 Department of Anatomy, J.N Medical College and Hospital, Belagavi, Faculty of Medicine, KLE Academy of Higher Education and Research, Deemed to be University, Belagavi, Karnataka, India- 59010, Belagavi, India

3 Department of Pathology, Zydus Medical College and Hospital, Dahod, Faculty of Medicine, Shri Govind Guru University, Godhra, Gujarat, India

4 Department of Obstetrics and Gynecology, Karnataka Medical College and Research Institute, Hubballi, Faculty of Medicine, Rajiv Gandhi University of Health Sciences, Bangalore, Hubballi, India

5 Department of Pathology, KLE Jagadguru Gangadhar Mahaswamigalu Moorusavirmath Medical College and Hospital, Hubballi, KLE Academy of Higher Education and Research, Deemed to be University, Belagavi, Karnataka, India- 59010, Faculty of Medicine, KLE Academy of Higher Education and Research, Deemed to be University, Belagavi, Karnataka, India- 59010, Hubballi, India

10.30699/ijp.2026.2074182.3559
Abstract
Background & Objective: Delayed Villous Maturation (DVM) is a histological hallmark in Gestational Diabetes Mellitus (GDM) pregnancies commonly observed after 36 weeks of gestation. It is associated with perinatal morbidity and mortality. Our study aims to assess DVM in the term placentas of GDM pregnancies and its association with its perinatal outcomes compared to normal pregnancies.
Methods: A total of 120 term placentae from GDM and normal pregnancies were collected from the Obstetrics and Gynaecology Department for one year and subjected to histopathological examination to evaluate DVM and its association with placental morphology and perinatal outcomes.
Results: The current study found statistically significant increased presence of DVM in GDM placentas and its association with placental weight, diameter, maternal weight, glycated haemoglobin and foetal weight. The present study also observed presence of DVM with chorangiosis in a GDM placenta. 
Conclusion: The present study has found a statistically significant association of DVM in GDM pregnancies with its perinatal outcomes compared to normal pregnancies. There is no antenatal ultrasound marker to detect placental DVM and adverse foetal outcomes caused due to it. Since there is risk of reoccurrence of DVM and type 2 diabetes in future pregnancies, identification of DVM in GDM pregnancies and its clinical association with foetal outcomes should be considered clinically important.  This may explain the cause of intrauterine foetal deaths and adverse neonatal outcomes in the current pregnancy and indicating a need for comprehensive maternal care in future pregnancies to prevent perinatal outcomes by implementing Rescue by birth.

Keywords

Subjects


1.      Abdelghany AH, Eissa TM, Idris S. Study of the ultrastructure of the placenta in gestational diabetes mellitus. Int J Anat Var. 2018;11(1):4-10.
2.      Sundari Amirthakatesan A, Devi Chandramohan S, Gurusamy U. The histomorphological spectrum of placenta in growth restricted fetuses in a tertiary care centre in South India. Iran J Pathol. 2023;18(1):12-23. [DOI:10.30699/ijp.2023.551426.2867] [PMID] [PMCID]
3.      Dharmalingam M, Murugan T, Rajamani P. Placental abnormalities and neonatal outcomes in gestational diabetes: a case-control study in northeast Tamil Nadu. SSR Inst Int J Life Sci. 2024;10(5):6145-54. [DOI:10.21276/SSR-IIJLS.2024.10.5.5]
4.      Ehlers E, Talton OO, Schust DJ, Schulz LC. Placental structural abnormalities in gestational diabetes and when they develop: a scoping review. Placenta. 2021;116:58-66. [DOI:10.1016/j.placenta.2021.04.005] [PMID] [PMCID]
5.      Korteweg FJ, Erwich JJ, Holm JP, Ravise JM, van der Meer J, Veeger NJ, et al. Diverse placental pathologies as the main causes of fetal death. Obstet Gynecol. 2009;114(4):809-17. [DOI:10.1097/AOG.0b013e3181b72ebe] [PMID]
6.      Higgins M, McAuliffe FM, Mooney EE. Clinical associations with a placental diagnosis of delayed villous maturation: a retrospective study. Pediatr Dev Pathol. 2011;14(4):273-9. [DOI:10.2350/10-07-0872-OA.1] [PMID]
7.      Redline RW. Distal villous immaturity. Diagn Histopathol. 2012;18(5):189-94. [DOI:10.1016/j.mpdhp.2012.02.002]
8.      Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler MA, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698-713. [DOI:10.5858/arpa.2015-0225-CC] [PMID]
9.      Soni S, Stevens A, Batra G, Heazell AE. Characterising delayed villous maturation: a narrative literature review. Placenta. 2024;158:48-56. [DOI:10.1016/j.placenta.2024.09.020] [PMID]
10.    Seshia V, Balaji V, Balaji MS, Sekar A, Sanjeevi CB, Green A. One step procedure for screening and diagnosis of gestational diabetes mellitus. J Obstet Gynecol India. 2005;55(6):525-9.
11.    Saha S, Biswas S, Mitra D, Adhikari A, Saha C. Histologic and morphometric study of human placenta in gestational diabetes mellitus. Ital J Anat Embryol. 2014;119(1):1-9.
12.    Shao J, Catalano PM, Yamashita H, Ruyter I, Smith S, Youngren J, et al. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes. 2000;49(4):603-10. [DOI:10.2337/diabetes.49.4.603] [PMID]
13.    Anjum S. Histomorphological alterations of placenta in normal vs gestational diabetes mellitus subjects: a case-control study. Int J Anat Radiol Surg. 2021;10(4):AO20-5. [DOI:10.7860/IJARS/2021/48786:2698]
14.    Seidmann L, Suhan T, Unger R, Gerein V, Kirkpatrick CJ. Imbalance of expression of bFGF and PK1 is associated with defective maturation and antenatal placental insufficiency. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):352-7. [DOI:10.1016/j.ejogrb.2013.06.045] [PMID]
15.    Treacy A, Higgins M, Kearney JM, McAuliffe F, Mooney EE. Delayed villous maturation of the placenta: quantitative assessment in different cohorts. Pediatr Dev Pathol. 2013;16(2):63-6. [DOI:10.2350/12-06-1218-OA.1] [PMID]
16.    Al-Adnani M, Marnerides A, George S, Nasir A, Weber MA. Delayed villous maturation in placental reporting: concordance among consultant pediatric pathologists at a single specialist center. Pediatr Dev Pathol. 2015;18(5):375-9. [DOI:10.2350/12-02-1604-OA.1] [PMID]
17.    Turowski G, Vogel M. Review and view on maturation disorders in the placenta. APMIS. 2018;126(7):602-12. [DOI:10.1111/apm.12858] [PMID]
18.    Huynh J, Yamada J, Beauharnais C, Wenger JB, Thadhani RI, Wexler D, et al. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta. 2015;36(10):1161-6. [DOI:10.1016/j.placenta.2015.08.004] [PMID] [PMCID]
19.    Giacometi C, Ludwig K, Guidi M, Colantuono E, Coracina A, Rigano M, et al. Gestational diabetes-placental expression of human equilibrative nucleoside transporter 1 (heNT1): is delayed villous maturation an adaptive pattern? Diagnostics (Basel). 2023;13(1):12. [DOI:10.3390/diagnostics13122034] [PMID] [PMCID]
20.    Arcot A, Walker RE, Gallagher K, Goldstein JA, Gernand AD. Gestational diabetes mellitus and vascular malperfusion lesions in the placenta: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2025;170:1071-83. [DOI:10.1002/ijgo.70127] [PMID] [PMCID]
21.    Seidmann L, Suhan T, Unger R, Gerein V, Kirkpatrick CJ. Transient CD15-positive endothelial phenotype in the human placenta correlates with physiological and pathological fetoplacental immaturity. Eur J Obstet Gynecol Reprod Biol. 2014;180:172-9. [DOI:10.1016/j.ejogrb.2014.06.022] [PMID]
22.    Higgins MF, Russell NM, Mooney EE, McAuliffe FM. Clinical and ultrasound features of placental maturation in pre-gestational diabetic pregnancy. Early Hum Dev. 2012;88(11):817-21. [DOI:10.1016/j.earlhumdev.2012.06.001] [PMID]
23.    Schafer-Graf UM, Dupak J, Vogel M, Dudenhausen JW, Kjos SL, Buchanan TA, et al. Hyperinsulinism, neonatal obesity and placental immaturity in infants born to women with one abnormal glucose tolerance test value. J Perinat Med. 1998;26(1):27-36. [DOI:10.1515/jpme.1998.26.1.27] [PMID]
24.    Daskalakis G, Marinopoulos S, Krielesi V, Papapanagiotou A, Papantoniou N, Mesogitis S, et al. Placental pathology in women with gestational diabetes. Acta Obstet Gynecol Scand. 2008;87(4):403-7. [DOI:10.1080/00016340801908783] [PMID]
25.    Madazli R, Tuten A, Calay Z, Uzun H, Uludag S, Ocak V. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Invest. 2008;65(4):227-32. [DOI:10.1159/000113045] [PMID]
26.    Lai YM, Tan GC, Shah SA, Rahman RA, Saleh MFM, Mansor S, et al. Non-hypertensive gestational diabetes mellitus: placental histomorphology and its association with perinatal outcomes. Placenta. 2024;147:21-7. [DOI:10.1016/j.placenta.2024.01.012] [PMID]
27.    Dasgupta S, Banerjee U, Mukhopadhyay P, Maity P, Saha S, Das B. Clinicopathological study and immunohistochemical analysis of expression of annexin A5 and apelin in human placentae of gestational diabetes mellitus. Diabetes Metab Syndr. 2022;16(3):102435. [DOI:10.1016/j.dsx.2022.102435] [PMID]
28.    El-Tarhouny SA, Almasry SM, Elfayomy AK, Baghdadi H, Habib FA. Placental growth factor and soluble Fms-like tyrosine kinase 1 in diabetic pregnancy: a possible relation to distal villous immaturity. Histol Histopathol. 2014;29(2):259-72.
29.    Jaiman S, Romero R, Pacora P, Jung E, Bhatti G, Yeo L, et al. Disorders of placental villous maturation in fetal death. J Perinat Med. 2020;48(4):345-68. [DOI:10.1515/jpm-2020-0030] [PMID] [PMCID]
30.    Jaiman S, Romero R, Pacora P, Erez O, Jung E, Tarca AL, et al. Disorders of placental villous maturation are present in one-third of cases with spontaneous preterm labor. J Perinat Med. 2021;49(4):412-30. [DOI:10.1515/jpm-2020-0138] [PMID] [PMCID]
31.    Jaiman S, Romero R, Bhatti G, Jung E, Gotsch F, Suksai M, et al. The role of the placenta in spontaneous preterm labor and delivery with intact membranes. J Perinat Med. 2022;50(5):553-66. [DOI:10.1515/jpm-2021-0681] [PMID] [PMCID]
32.    Jaiman S, Romero R, Pacora P, Jung EJ, Kacerovsky M, Bhatti G, et al. Placental delayed villous maturation is associated with evidence of chronic fetal hypoxia. J Perinat Med. 2020;48(5):516-8. [DOI:10.1515/jpm-2020-0014] [PMID] [PMCID]
33.    Sethy PP, Ghosh S, Nanda S, Sahu M. Clinicopathological comparison of histopathology of placentae in GDM compared with that of uncomplicated pregnancy and perinatal outcome in GDM mothers in different interventions in pregnancy. J Popul Ther Clin Pharmacol. 2024;31(5):1285-94.
34.    Lateef RH, AbdAlzahra JM. Placental vasculogenesis and angiogenesis related to GDM and the possible affect on the placenta and the fetus outcome. Med Legal Update. 2020;20(4):1962-9.
35.    Tayel SM, Zaki MG, Metwally ES. Morphometric and structural changes of the placenta of gestational diabetics. Am J Clin Anat Physiol. 2021;3(1):5-9.
36.    O'Hare CB, Mangin-Heimos KS, Gu H, et al. Placental delayed villous maturation is associated with fetal congenital heart disease. Am J Obstet Gynecol. 2023;228(2):231.e1-231.e11. [DOI:10.1016/j.ajog.2022.08.013] [PMID] [PMCID]
37.    Krstevska SS, Nakova VV, Samardziski I, Bosku AA, Todorovska I, Sima A, et al. Perinatal outcome in gestational diabetes mellitus vs normoglycemic women. Biomed J Sci Tech Res. 2020;26(2):19882-8. [DOI:10.26717/BJSTR.2020.26.004338]
38.    Arizawa M, Nakayama M, Kidoguchi K. Correlation of placental villous immaturity and dysmaturity with clinical control of maternal diabetes. Nihon Sanka Fujinka Gakkai Zasshi. 1991;43(6):595-602.
39.    Edu A, Teodorescu C, Dobjanschi CG, Socol ZZ, Teodorescu V, Matei A, et al. Placenta changes in pregnancy with gestational diabetes. Rom J Morphol Embryol. 2016;57(2):507-12.
40.    Natarajan L, Maheswari GU. Gestational hyperglycemia on diet and medication: impact on placental pathology and pregnancy outcomes. Int J Reprod Contracept Obstet Gynecol. 2019;8(8):3350-6. [DOI:10.18203/2320-1770.ijrcog20193564]
41.    Arshad R, Kanpurwala MA, Karim N, Hassan JA. Effects of diet and metformin on placental morphology in gestational diabetes mellitus. Pak J Med Sci. 2016;32(6):1522-7. [DOI:10.12669/pjms.326.10872] [PMID] [PMCID]
42.    Venkatesh MK, Shetty SK, Chaithra GV. Morphological and histopathological features of placenta in women with gestational diabetes mellitus and its association with perinatal outcome. J South Asian Feder Obs Gynae. 2024;16(S1):S1-6. [DOI:10.5005/jp-journals-10006-2389]
43.    Marijnen MC, Ganzevoort W, Gordijn SJ, van der Meeren LE. Delayed villous maturation with and without fetal demise: a case report of three successive pregnancies. J Obstet Gynaecol Res. 2025;51(5):1-7. [DOI:10.1111/jog.16308] [PMID] [PMCID]
44.    Stallmach T, Hebisch G, Meier K, Dudenhausen JW, Vogel M. Rescue by birth: defective placental maturation and late fetal mortality. Obstet Gynecol. 2001;97(4):505-9. [DOI:10.1097/00006250-200104000-00005] [PMID]
45.    Matsika A. Clinical correlates of histopathological entities of the placenta. Aust J Gen Pract. 2021;50(1-2):62-9. [DOI:10.31128/AJGP-11-19-5154] [PMID]

Articles in Press, Accepted Manuscript
Available Online from 25 February 2026

  • Receive Date 02 September 2025
  • Revise Date 02 December 2025
  • Accept Date 03 February 2026